DK599589A - Anvendelse af substituerede benzimidazoler eller benztriazoler til fremstilling af laegemidler mod epithellidelser - Google Patents

Anvendelse af substituerede benzimidazoler eller benztriazoler til fremstilling af laegemidler mod epithellidelser

Info

Publication number
DK599589A
DK599589A DK599589A DK599589A DK599589A DK 599589 A DK599589 A DK 599589A DK 599589 A DK599589 A DK 599589A DK 599589 A DK599589 A DK 599589A DK 599589 A DK599589 A DK 599589A
Authority
DK
Denmark
Prior art keywords
epithel
benztriazoles
diseases
preparation
medicinal products
Prior art date
Application number
DK599589A
Other languages
English (en)
Other versions
DK175793B1 (da
DK599589D0 (da
Inventor
Jean Pierre Franz Van Wauwe
Alfons Herman Marg Raeymaekers
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK599589D0 publication Critical patent/DK599589D0/da
Publication of DK599589A publication Critical patent/DK599589A/da
Priority to DK200401449A priority Critical patent/DK175785B1/da
Application granted granted Critical
Publication of DK175793B1 publication Critical patent/DK175793B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198905995A 1988-11-29 1989-11-28 Substituerede benzimidazoler, deres fremstilling samt anvendelse til fremstilling af lægemidler mod epitellidelser DK175793B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200401449A DK175785B1 (da) 1988-11-29 2004-09-23 Topicale formuleringer omfattende benzimidazoler og benzotriazoler

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27715288A 1988-11-29 1988-11-29
US27715288 1988-11-29

Publications (3)

Publication Number Publication Date
DK599589D0 DK599589D0 (da) 1989-11-28
DK599589A true DK599589A (da) 1990-05-30
DK175793B1 DK175793B1 (da) 2005-02-21

Family

ID=23059616

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198905995A DK175793B1 (da) 1988-11-29 1989-11-28 Substituerede benzimidazoler, deres fremstilling samt anvendelse til fremstilling af lægemidler mod epitellidelser

Country Status (16)

Country Link
EP (2) EP0609963B1 (da)
JP (2) JP2752200B2 (da)
AT (2) ATE112681T1 (da)
AU (2) AU623454B2 (da)
CA (1) CA2002859C (da)
CY (1) CY1867A (da)
DE (2) DE68929377T2 (da)
DK (1) DK175793B1 (da)
ES (2) ES2065369T3 (da)
HK (1) HK114895A (da)
IE (1) IE63877B1 (da)
IL (1) IL92487A (da)
NZ (1) NZ231405A (da)
PT (1) PT92449B (da)
SG (1) SG50466A1 (da)
ZA (1) ZA899074B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
PL176059B1 (pl) * 1992-11-10 1999-03-31 Janssen Pharmaceutica Nv Sposób wytwarzania enancjomerycznie czystego 6-[(4-chlorofenylo) (1H-1,2,4-triazol-1-ilo)-metylo]-1-metylo-1H-benzotriazolu
CN1141042A (zh) * 1994-02-18 1997-01-22 詹森药业有限公司 旋光对映纯的(+)-利罗唑
TW418203B (en) * 1994-02-18 2001-01-11 Janssen Pharmaceutica Nv Enantiomerically pure (-)-liarozole
EP0800391A1 (en) * 1994-12-28 1997-10-15 Janssen Pharmaceutica N.V. Benzimidazoles as inhibitors of calcitriol metabolism
TW316902B (da) * 1994-12-28 1997-10-01 Janssen Pharmaceutica Nv
US5536740A (en) * 1995-06-01 1996-07-16 Elizabeth Arden Company, Division Of Conopco, Inc. Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
KR100365312B1 (ko) * 1996-06-27 2003-03-06 얀센 파마슈티카 엔.브이. N-[4-(헤테로아릴메틸)페닐]헤테로아릴아민
JPH10220909A (ja) 1996-12-03 1998-08-21 Komatsu Ltd 流体温度制御装置
TW591030B (en) 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
JP2001525400A (ja) 1997-12-11 2001-12-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ レチノイン酸擬似アニリド
JP2002518387A (ja) * 1998-06-16 2002-06-25 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス イミダゾリル誘導体
US6420555B1 (en) 1998-06-16 2002-07-16 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
WO2000066077A1 (en) * 1999-04-29 2000-11-09 Avon Products, Inc. Method of improving the aesthetic appearance of epithelia
EP1420015A1 (en) * 1999-06-11 2004-05-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Imidazolyl derivatives
FR2815857B1 (fr) * 2000-10-30 2003-02-14 Oreal Composition, notamment cosmetique, renfermant un retinoide et une silicone benzotriazole
US7405235B2 (en) 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
JP2006513162A (ja) * 2002-11-01 2006-04-20 パラテック ファーマシューティカルズ インコーポレイテッド 転写因子調節化合物およびその使用方法
US20060160799A1 (en) 2004-04-23 2006-07-20 Alekshun Michael N Transcription factor modulating compounds and methods of use thereof
BR112012016398B1 (pt) 2009-12-30 2021-12-21 Arqule, Inc Composto imidazopiridinil-aminopiridino substituído, composição farmacêutica que compreende o referido composto e uso do mesmo para o tratamento de uma doença celular proliferativa
WO2012177852A1 (en) 2011-06-24 2012-12-27 Arqule, Inc Substituted imidazopyridinyl compounds
KR20190015600A (ko) 2011-06-24 2019-02-13 아르퀼 인코포레이티드 치환된 이미다조피리디닐-아미노피리딘 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859684A (en) * 1986-09-15 1989-08-22 Janssen Pharmaceutica N.V. (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders

Also Published As

Publication number Publication date
JPH0320273A (ja) 1991-01-29
AU4564889A (en) 1990-06-07
DE68929377T2 (de) 2002-10-31
DK175793B1 (da) 2005-02-21
DK599589D0 (da) 1989-11-28
ATE213941T1 (de) 2002-03-15
NZ231405A (en) 1991-08-27
CA2002859C (en) 1998-12-29
JP2752200B2 (ja) 1998-05-18
JP2912596B2 (ja) 1999-06-28
EP0609963B1 (en) 2002-03-06
PT92449B (pt) 1995-07-18
IL92487A (en) 1994-12-29
IE950033L (en) 1990-05-29
DE68918809T2 (de) 1995-03-23
IE63877B1 (en) 1995-06-14
SG50466A1 (en) 1998-07-20
IL92487A0 (en) 1990-08-31
AU623454B2 (en) 1992-05-14
ES2065369T3 (es) 1995-02-16
CA2002859A1 (en) 1990-05-29
ES2173902T3 (es) 2002-11-01
EP0609963A1 (en) 1994-08-10
EP0371559A3 (en) 1992-04-08
DE68918809D1 (de) 1994-11-17
JPH1095782A (ja) 1998-04-14
EP0371559B1 (en) 1994-10-12
AU630579B2 (en) 1992-10-29
ATE112681T1 (de) 1994-10-15
ZA899074B (en) 1991-07-31
IE893781L (en) 1990-05-29
HK114895A (en) 1995-07-21
EP0371559A2 (en) 1990-06-06
DE68929377D1 (de) 2002-04-11
PT92449A (pt) 1990-05-31
CY1867A (en) 1996-04-05
AU1071692A (en) 1992-03-19

Similar Documents

Publication Publication Date Title
DK599589D0 (da) Anvendelse af substituerede benzimidazoler eller benztriazoler til fremstilling af laegemidler mod epithellidelser
PL268455A1 (en) The method of manufacture of new derivatives of benzimidazole
FI101964B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten (1H-atsol-1-yylimetyyli)substituoitujen kinoliini-, kinatsoliini- ja kinoksaliinijohdannaisten valmistamiseksi
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
EP0050286A3 (en) Novel pharmaceutical guanidine derivatives
FI872930A (fi) Analogiamenetelmä ripulinvastaisten 4-(bentsoyyliamino)piperidiinibutaaniamidijohdannaisten valmistamiseksi
DE3684186D1 (de) Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
ATE167869T1 (de) Thiolderivate von gallensäure
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
JPS6452772A (en) Pyridylpyrimidine derivative, production thereof and plant disease controlling agent containing said derivative as active ingredient
NZ228720A (en) Benzenesulphonamides and pharmaceutical compositions thereof
IT1173763B (it) Derivati dell'acido 3-mercapto-2-oxo-1-pirrolidinacetico,procedimento di preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
PUP Patent expired